Special thanks to the Gidday lab for their work in developing the RHP protocol, as well as the Neuro-Models Facility (UTSW) for their assistance in the tMCAo surgeries. This work was supported by grants from the American Heart Association (AMS), The Haggerty Center for Brain Injury and Repair (UTSW; AMS), and The Spastic Paralysis Research Foundation of the Illinois-Eastern Iowa District of Kiwanis International (JMG).

注：此协议被批准的机构动物护理和使用委员会（IACUC）在得克萨斯大学西南医学中心这为健康（NIH）的政策实验动物的使用遵循全国学院。 1.重复缺氧预处理<ol><li>定制设计上的气体调节器4流量计和附加到标准15升感应腔与PVC管，以允许压缩气体从氧气（O 2）的罐，以经由入口端口流入所述腔室。看装备和材料有关自定义设计的更多细节。 </li><li>小鼠分成2组：重复缺氧预处理（RHP）集团，该集团接受暴露于8％和11％O 2，和对照组，其中接收暴露于21％O 2（室内空气）兼任。请参考表1中的频率变化，强度（图8和11％的O 2或21％的O 2），和RHP暴露的持续时间（2或4小时）。&lt;/ LI&gt; <li>删除每个笼子的顶部过滤器盖板，将笼，食物和水的瓶子完好，在连接到各自的O 2坦克室。关闭并固定室的盖。 <ol><li>打开该罐的主气阀，并设置为每个感应腔室的初始流量为每分钟（LPM）的2L曝光的前5分钟。降低流速为1 LPM对于曝光的其余部分。 </li><li>在曝光结束时，减少流至0 LPM和关闭气体阀门的坦克。 </li><li>打开盖子室和更换滤芯顶盖上的每个笼子里。地方标准的住房笼，直到下一次低氧暴露。 </li></ol></li><li>喷绒与NPD（Steris的），或者在每次使用后的等效消毒/除臭每个感应室。 </li><li>在一天两周的过程中的同时露出两个21％和RHP小鼠如表1所述。 </li></ol> 2.瞬态大脑中动脉闭塞（tMCAo） <ol><li>见讨论关于中风的时机下最终RHP曝光更多细节。 </li><li>准备一个无菌的手术工作。清洁周围的工作场所，用70％乙醇或等效消毒和高压灭菌的所有外科手术工具。 <ol><li>设置了激光多普勒血流仪（LDF）仪器测量脑血流量（CBF）的相对变化。打开加热垫至37℃。打开孵化器34℃。 </li></ol></li><li>麻醉小鼠一短暂暴露于4％的异氟醚/ 70％ 的 NO 2/30％O 2的混合在一个小感应腔室。轻轻捏爪子确认适当的麻醉。如果鼠标撤回它的爪子，返回鼠标的感应室，继续异氟醚曝光。 </li><li>从麻醉诱导室取出小鼠和快速插入鼠标的鼻子的鼻锥。打开气流到鼻锥，封闭流向ANESthesia感应室。 <ol><li>在不改变70％ 的 NO 2/30％O 2的混合气体，异氟醚固定在1.8％的维持剂量为程序的剩余部分。呼吸要保持缓慢，在整个过程中定期但是如果呼吸变得急促而浅，增加了异氟醚剂量。维持剂量可以在实验中使用的设备的制造和动物之间变化。 </li></ol></li><li>使用microshaver，剃除毛发上的时间区域中的眼睛的角部和所述耳以及颈部腹侧中线之间。去除多余的皮毛和应用眼部润滑剂用无菌棉签保持角膜的过程中干燥。擦拭用酒精垫和棉签providone碘用无菌棉签切口区保持无菌条件。 </li><li>根据啮齿类动物外科手术指导管理止痛药。 </li><li>通过眼睛和耳朵之间的时间皮肤做一个切口。暴露颞肌。手术采用微型剪刀，剪颞肌韧带在白肌条纹区域内的时间山脊。 <ol><li>轻轻横向推肌肉体积用钳子以可视化的大脑中动脉（MCA）通过头骨。颞肌切开后，该地区可能会充满血液。轻轻用棉签止住任何潜在的出血。 </li><li>目标的LDF探头端部与马华区。记录选为小鼠之间这方面的变化船只。 </li><li>保持就位并平齐的LDF与颅骨直到稳定红细胞通量被读取并记录该值作为基线CBF。在激光多普勒血流仪理想基线CBF是&gt; 600通量，但是这将随制造商。如果基线CBF是&lt;400磁通，流记录是最有可能从附近的静脉，或探针在目标容器的一个不完整的位置。 </li></ol></li><li>后基线CBF被建立，repositi鼠标上使颈部露出。支持它的头，并保持鼠标在稳定麻醉从鼻锥。 </li><li>建立从略低于下颌到锁骨下腹正中切口。 <ol><li>使用镊子，钝解剖所有浅筋膜，以暴露左颈总动脉（CCA）。由结缔组织和迷走神经分离CCA。 </li><li>永久结扎CCA用6.0丝线缝合。将缝线结扎近端为尽可能地留出足够的空间闭塞灯丝位置。 </li><li>循环和松散的领带绕CCA远端第二丝线缝合6.0的遮挡缝合。要小心，不要堵塞动脉的闭塞长丝随后将通过颈螺纹。 </li><li>使用8×2mm的光微serrafine areterial夹子夹住CCA远端松散绑丝线缝合。轻轻提起CCA钳和做一个小切口纵，因为近端缝合结扎作为可能为3 mm vannas。 </li><li>通过切口螺纹12mm的涂硅6.0轨距尼龙阻塞长丝进入动脉管腔，然后前进它几个毫米。松散收紧阻塞丝的尖端周围的二次宽松丝线缝合，以确保血液流动不压灯丝了CCA和消除动脉夹。 </li><li>在CCA到颈内动脉（ICA）和外部颈动脉（ECA）的第一分叉，螺纹闭塞灯丝到第一分叉的右分支进入ICA.Advance闭塞灯丝9至10.5毫米过去第二丝线缝合到左内颈动脉（ICA）。 </li><li>进入ICA后不久，提前阻塞长丝进入左分支在ICA和pterogopalantine动脉（PPA）之间的第二分叉。苯丙醇胺的可视化是不可能这样继续，直到你觉得与遮挡丝满放置一个温和的阻力。起重ICA用钳子可以帮助长丝更容易线程进入第二birfurcation左支。收紧第二丝线。 </li><li>将鼠标使切口在MCA是可见的。随着LDF设备，确认CBF通过LDF读数受阻。一个成功的闭塞是从基线CBF减少&gt; 80％。 </li><li>完全收紧，双结周围的阻塞长丝第二丝线缝合的时候适当的位置来实现的。如果必要的话，稍微推入或拉出细丝遮挡实现CBF标准成功闭塞（从基线CBF 如 &gt; 80％降低）。 </li><li>关闭颈部和头部开口6.0尼龙缝合线。 </li></ol></li><li>地方小鼠在34℃培养箱为闭塞的持续时间。闭塞的推荐长度是60分钟，但是这对于改变脑血管解剖，25岁，应变依赖差异和injur程度Ÿ所需的（轻度，中度，重度）。确保动物脱落麻醉分钟内恢复意识。 </li><li>重新麻醉动物用异氟醚，如步骤2.3中所述，5分钟的预先定义的闭塞期结束前，打开头皮切口，并确认MCA灌注经颅LDF读数依然减少。如果脑血流量的减少不充分（ 例如，&lt;20％基线CBF），在MCA已经闭塞期间再灌注在一些点和鼠标应排除进一步的实验。 </li><li>打开中线颈切口和松散捆绕CCA第三丝线，远端向第二丝线缝合但近端CCA分叉，以确保外颈动脉（ECA）将保持存活灯丝移除之后。 <ol><li>剪切或解开持有闭塞长丝（ 即第二丝线缝合）结 ​​和撤销封闭丝缓慢。一旦取出，迅速关闭周围的CCA第三丝线从ICA尽量减少血液回流。双结这个缝合关闭切口用6.0尼龙缝合线。 </li><li>重新定位鼠标5分钟再灌注后，以量化的CBF的水平。再灌注成功通常被定义为基线脑血流量&gt; 50％的CBF，但与闭塞流，研究者可以建立自己的标准。如果动物呈现低于基线50％的CBF，则很可能在MCA是“永久”闭塞，因而表示另一研究排除标准。 </li><li>关闭两个切口用6.0尼龙缝合线。根据啮齿动物准则提供盐水，麻醉剂（利多卡因）和抗生素。然而，一些小剂量的抗生素（3毫克/公斤的二甲胺四环素的）已经被发现是神经保护以下中风。26 </li></ol></li><li>经过手术后，老鼠的地方在一个无​​尘，无菌笼子里苏醒的恒温培养箱。提供湿润FOOd或营养水合膳食凝胶补充剂和水的培养皿作为动物将具有受限制的流动性中风。恢复过度术后疼痛和死亡过程中密切监测动物。 </li></ol> 3.伊文思蓝（EB）注射<ol><li>再灌注后注射EB 22小时，并在血液中循环应该为以牺牲和TTC染色前2小时。 </li><li>使注射（在盐水中的2％的EB）使用EB溶液并轻轻混合，在室温下进行。过滤通过滤纸或溶液通过附连到一个小注射器以除去未溶解的EB，并储存在室温下0.2微米的过滤器推。 </li><li>制备所需要的注射EB的量（4毫升/公斤体重）画出染料所需量成0.3毫升的胰岛素注射器用29号针头，并确保该溶液是在室温下<ol><li>采用平底阻挡抑制鼠标。握住尾巴，这样的侧脉是UPPermost。侧脉位于尾部的中心线的两侧。抓住尾巴尖，以保持稳定的老鼠注射。 </li><li>针插入静脉约3.5毫米，小心不要刺穿静脉。确认针头是在静脉通过绘制背面上的注射器和寻找血迹。 </li><li>注入所有的染料在1分钟的过程。如果溶液是进入静脉应该有最小的阻力作为压力施加到注射器。在尾部，四肢，鼠标的眼睛立即变色确认EB成功的全身静脉给药。 </li><li>取下尾针，轻轻地用干净的纱布，以止血施加压力。 </li></ol></li><li>开始计时，当鼠标的皮肤变成蓝色。允许在EB循环2小时穿透减弱血脑屏障。 </li></ol> 4. 2,3,5-氯化三苯基四唑（TTC）染色</P&gt; <ol><li>灌注和TTC染色应该出现再灌注后24小时。 </li><li>准备处死前的指定时间为2％TTC解决方案。添加10克TTC粉末的500ml的0.01M磷酸盐缓冲盐水（PBS），pH 7.4中。在水浴热溶液至37℃，以方便的TTC的增溶。 注意：TTC粉和解决方案是一种皮肤，肺，眼睛有刺激性。处理这些材料时，穿戴合适的个人防护装备。 <ol><li>一旦粉末完全溶解后，立即转移至瓶中，盖以箔，并储存在4℃。 TTC和组织沾上TTC是对光敏感。 </li></ol></li><li>在tMCAo后24小时和EB给药后2小时时，牺牲动物提供在一个小感应室中的异氟醚过量。灌注应立即开始下sacricice以尽量减少自溶它开始于以下死亡缺氧的情况下。 </li><li>快速保护动物在泡沫塑料平台前臂通过爪子固定。从正下方的胸腔的中线切穿过腹壁的横向切口。通过隔膜小心切割以暴露心脏。 <ol><li>开始灌流泵以5毫升/分钟的流速用60毫升注射器填充用冰冷的0.01M PBS中并连接到一个27瓜哥翅输液针。将针约0.5cm到心脏的左心室的点尖和剪切右心房。逐步稀释静脉血应该灌注过程中流出的中庭，直到静脉血出现无色。 Transcardially灌注30毫升0.01M磷酸盐缓冲盐水（PBS）通过心脏。 </li></ol></li><li>加入5毫升的TTC溶液成透明20闪烁瓶。 </li><li>紧随灌注，杀头的动物和解剖出用小剪刀和锅铲，如果必要的大脑。检查大脑，排除动物，经历了蛛网膜下腔hemorrhaGE在Willis环，二次缝合位置。检查对侧半球闭塞马华出现面色苍白，没有明显的EB渗漏或水肿。 </li><li>倾的PBS成丙烯酸大脑基质旨在使鼠脑的1.0mm厚的冠状切片。放置脑，背侧，进入基质，并立即倒入PBS在大脑。养脑湿润。 <ol><li>通过插入一个不锈钢0.21毫米厚刀片成从矩阵的喙侧的第二插槽中取出嗅球。 </li><li>通过从基体的尾侧上的第四时隙中插入一个刀片除去小脑。 </li><li>插入一个刀片成在基质中的剩余的槽的中间槽。插入其余刀片，均匀地平分剩余组织，以确保在切片过程中最均匀分布的组织。 </li><li>一旦所有的刀片已插入，添加1〜2滴PBS中至脑滋润它。 </li><li>卸下刀片■一个在从基质与延髓区域开头的时间。保持前7切片TTC分析tMCAo后。用小铲小心从叶片到TTC填充小瓶转移的切片。 </li></ol></li><li>毕竟部分是在小瓶中，盖住它，并在温水浴放置，直到部分变成粉红色。轻轻转动瓶子在浴如有必要，以避免部分重叠，这可能导致不均匀的染色。然后处置TTC和倒4％多聚甲醛溶液放入小瓶覆盖脑切片终止TTC化学反应。 </li><li>立即安排在一个干净的1“×3”搏命的部分和定向部分从吻端至尾。 <ol><li>当该部分被布置在滑动，使用标准扫描器扫描的幻灯片。设置分辨率最低为600 dpi的图像分析。一定要包括动物的名称和扫描图像中的米尺。 </li><li>翻转过来幻灯片和扫描背侧，以确保收集的所有数据。 </li></ol></li></ol> 5.脑梗死体积的定量<ol><li>通过使用标准图像分析软件（ 例如，ImageJ的）量化梗塞体积。 </li><li>扫描图像以高分辨率（ 如 600 DPI）进行充分的分析。裁剪图像。标准化规模为用米尺包括扫描图像中的所有图像。 </li><li>计算使用下面的公式对侧半球的总体积。重复此公式计算同侧半球的总体积。 每个片X层厚总对侧半球的总和</li><li>计算间接梗死体积。 。控制中风同侧水肿使用健康，对侧作为对照27使用下面的公式来计算间接梗死体积： 对侧大脑半球的总体积 - （总volum3次测量梗死电子同侧半球的体积 - 平均） </li></ol> 6.血脑屏障（BBB）完整性定量<ol><li>为了准备EB定量，先掂量2.5英寸称量皿。记录重量并标记2称量皿每个动物：一个用于同侧半球，一个用于对侧半球。 </li><li>扫描TTC染色切片后，平分每个部分用一次性刀片到同侧和对侧半球。将所有7个部分同侧半球一掂船，记录重量。重复对侧半球。 </li><li>紧接重量船转移到烘箱组为56℃48小时。 </li><li>称取干燥的部分。转移两个半球到单独的1.5 ml离心管中。 <ol><li>计算所需要的每一个半球甲酰胺的量（8毫升/克干组织），并添加到它们各自microcentrifugË管。甲酰胺是对光敏感，覆盖铝箔全部甲酰胺处理的样品，从这个点开始。 </li><li>转移离心管至培养箱设定为56℃另外48小时。 </li></ol></li><li>经过48小时，吸取了蓝色上清到另一组标记的离心管中。推组织到管的底部，以最大限度地提取上清液的体积。保持上清液管和处置所有组织。 </li><li>在甲酰胺制备的EB指数系列稀释的标准曲线。包括通过EB的甲酰胺64微克/毫升1空白（甲酰胺只），然后用10指数0.125溶液微克/毫升。 <ol><li>吸液管将300μl标准曲线所作的稀释液到96孔板中。移液器将300μl上清液成相应的孔中。 </li><li>测量在分光光度计上在620nm的吸光度。 </li><li>与吸收Ø比较EB稀释的标准曲线f显示上清样品。的光密度成正比血脑屏障的完整性。 </li><li>假定对侧半球作为背景的​​光密度，并使用式（同侧-对侧）/对侧，以确定倍数变化。有关统计分析，进一步的细节参见Martin 等人 ，2010年18 </li></ol></li></ol>

The authors have nothing to disclose.

单次暴露于全身缺氧（ 即人力资源，2 11％O 2）在小鼠“瞬时”免受tMCAo，29大脑意义缺氧预处理挑战后生反应是持续时间短，基线表型内恢复天。缺氧预处理刺激重复演示大大延长神经保护型的持续时间。6，许多研究表明，频率，幅度和持续时间的反复刺激训练都是这种反应的关键因素。例如，简单地重复同样的强度和缺氧的持续时间（2小时的11％的氧气）...

成人残疾和死亡的第四大病因的主要原因，中风是美国面临的成人人口中最衰弱的疾病之一。卒中1动物模型允许对减少缺血性损伤的新方法和实验研究改善中风后恢复。一个新的途径，例如翻译研究的预处理。预处理是有意使用的非破坏性的刺激，以减少从随后，和更严重的，损伤的破坏。2缺氧预处理已经显示出产生在大脑中的多效性的变化提供保护，防止中风在体内和体外研究3，当然 ，单次曝光缺氧只提供短期的神经保护作用，诱导少于72小时耐受缺血的成年小鼠的4连四个星期后的14小时日常暴露在低压缺氧，林等人。 FOUND的神经保护作用只持续了一个星期。5重复缺氧预处理（RHP）的特点是频率，持续时间和低氧暴露强度随机变化。在对比一个单一预处理挑战，RHP诱导脑保护表型，持续长达八周的小鼠。6 RHP减少梗死体积，血-脑屏障（BBB）的破坏，血管炎，和白细胞血细胞渗出数周的最后低氧暴露后。 RHP特别通过降低T细胞，单核细胞，和巨噬细胞群体，同时维持B细胞群体中的缺血性半球炎症减少了缺血性脑7实际上，RHP任何CNS损伤诱导小鼠免疫表型之前，包括中风。 RHP处理的B细胞从RHP处理健康小鼠中分离表现出独特的抗炎表型，具有两个抗原呈递和抗体产生的下调。该在促炎症性免疫机制的整体减少使得RHP极好方法，以诱导内源免疫抑制不仅CNS特异性炎性疾病，而且全身的损伤或疾病的模型，其中包括一个促炎性病理。 RHP降低了梗死体积和血脑屏障破坏下一个暂时性大脑中动脉闭塞（tMCAo）。中风的动物模型，如常用的tMCAo，显着地提高中风的病理生理学的了解，以及更有效的neurotherapeutics设计。首先由小泉等人开发的。，1986年，8 tMCAo过程是诱导中风在啮齿类动物和优选的方法为以下灌注调查炎症一个的广泛使用的方法。作为方法tMCAo演进，更多的近期使用的有机硅涂覆的长丝进一步减少相对于其他模型9,10 &lt;蛛网膜下腔出血的风险/ SUP&gt;，提高了可靠性，但不幸的tMCAo往往产生于梗死体积变化很大。11-13这些研究大多描绘的冠状脑切片梗死区与2,3,5-三苯基氯化（TTC）染色，被认为是金标准梗死定量，因为它是产生生动的，可复制的结果的简单和廉价的方式。 TTC用作存在于线粒体脱氢酶的底物。当脑切片暴露在TTC溶液中，TTC选择性考虑活细胞，其中其非水溶性还原产物，甲，沉淀到深红色存活线粒体。因为在缺血组织线粒体功能障碍的，这个组织保持白色，使受损和健康组织的分化。14 RHP也减少了在缺血半球血脑屏障破坏。6因此，血脑屏障完整性的双重定量同一B内部降雨作为TTC基梗塞体积测定15将提供大约源性保护的充分发挥药效的有用信息，并在未处理的和处理的动物血脑屏障破坏和梗死之间潜在的因果关系。外周血通过具有破坏血脑屏障，继发于中风，潮增加白细胞群，促炎性细胞因子，氧化应激，血管性水肿，和出血性转化中的缺血性半球，最终增加了感染和死亡的发生率在缺血性脑卒中患者16,17测量血脑屏障损伤的动物模型中的常用方法是通过定量的伊文思蓝（EB）的染料泄漏入脑。15,18-21 EB选择性地结合血清白蛋白，球状蛋白质（MW = 65 kDa）的不穿过BBB在未受伤的动物。22继缺血性中风，EB渗入脑和荧光在620nm，允许光密度withi的测量n中的灌注损伤实质22的光密度成正比血脑屏障的时EB已经洗出的验尸皮质脉 ​​管由transcardiac灌注的渗透性。随着动物EB管理TTC染色大脑的即时处理，既梗死体积和血脑屏障破坏，可以有效地量化。应当指出，然而，神经元损伤和血脑屏障破坏不是在中风后大脑伴随工序，23,24这样的牺牲的时间的选择是一个重要的考虑因素。 接下来的协议细节的RHP方法，该tMCAo方法用于诱导临时动脉闭塞该模型中脑动脉闭塞在人类患者，和双组织学方法，用于确定神经和血管中风损伤端点。 TTC测量细胞死亡和累积的组织损伤，从而允许整体梗塞体积的量化乌梅，而电子束提供的血脑屏障损伤的半球定量。

<table border="0" cellpadding="0" cellspacing="0" width="830">
	<tbody>
		<tr height="42">
			<td height="42" style="height:42px;width:249px;">Material/ Equipment</td>
			<td style="width:171px;">Company</td>
			<td style="width:127px;">Catalog Number</td>
			<td style="width:283px;">Comments/Description</td>
		</tr>
		<tr height="220">
			<td height="220" style="height:220px;width:249px;">Flowmeters, regulators</td>
			<td style="width:171px;">VetEquip, Inc</td>
			<td style="width:127px;">Specialty order</td>
			<td style="width:283px;">Four flowmeters are attached to 6.0 mm flexible PVC tubing which connects to the inlet port on each induction chamber with a plastic female connector. These flowmeters are bolted to a 6.5&#34; x 1&#34; x 1&#34; metal bar. This metal bar is bolted to a MI-246-P pressure gauge with a DISS outlet. This pressure gauge and flowmeter equipment can be attached to each new gas cylinder with a wrench.</td>
		</tr>
		<tr height="26">
			<td height="26" style="height:26px;width:249px;">21% O2 tank</td>
			<td style="width:171px;">AirGas</td>
			<td style="width:127px;">OX USP200</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="26">
			<td height="26" style="height:26px;width:249px;">11% O2 tank</td>
			<td style="width:171px;">AirGas</td>
			<td style="width:127px;">Specialty order</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="26">
			<td height="26" style="height:26px;width:249px;">8% O2 tank&#160;</td>
			<td style="width:171px;">AirGas</td>
			<td style="width:127px;">Specialty order</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">15L induction chambers</td>
			<td style="width:171px;">VetEquip</td>
			<td style="width:127px;">941454</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">Moor Laber Dopper Flow&#160;</td>
			<td style="width:171px;">Moor Instruments&#160;</td>
			<td style="width:127px;">moorVMS-LDF1-HP</td>
			<td style="width:283px;">0.8mm diameter probe&#160;</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">High Intensity Illuminator&#160;</td>
			<td style="width:171px;">Nikon</td>
			<td style="width:127px;">NI-150</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">Zoom Stereo Microscope&#160;</td>
			<td style="width:171px;">NIkon</td>
			<td style="width:127px;">SMZ800</td>
			<td style="width:283px;">Other surgical microscopes may be used.&#160;</td>
		</tr>
		<tr height="100">
			<td height="100" style="height:100px;width:249px;">Kent Scientific Right Temperature CODA</td>
			<td style="width:171px;">Kent Scientific Corporation</td>
			<td style="width:127px;">Discontinued</td>
			<td style="width:283px;">Recommended replacement is PhysioSuite with RightTemp Temperature Monitoring and Homeothermic Control (Kent Scientific, #PS-RT).</td>
		</tr>
		<tr height="60">
			<td height="60" style="height:60px;width:249px;">Hovabator Incubator</td>
			<td style="width:171px;">Stromberg&#39;s</td>
			<td style="width:127px;">2362-E</td>
			<td style="width:283px;">Our model is the 2362N. 2362E is a later model and includes an electronic thermostat.&#160;</td>
		</tr>
		<tr height="120">
			<td height="120" style="height:120px;width:249px;">V010 Anesthesia system&#160;</td>
			<td style="width:171px;">VetEquip</td>
			<td style="width:127px;">901807</td>
			<td style="width:283px;">Includes: ten foot high-pressure oxygen hose, frame, flowmeter, oxygen flush assembly, vaporizer, breathing circuit, chamber, nosecones, waste gas evacuation tubing and two VapoGuard filters</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">250 mL isoflurane&#160;</td>
			<td style="width:171px;">Butler Schein</td>
			<td style="width:127px;">NDC-11695</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">D-6 Vet Trim Animal Cordless Trimmer&#160;</td>
			<td style="width:171px;">Andis&#160;</td>
			<td style="width:127px;">#23905</td>
			<td style="width:283px;">Replacement blades are available from Andis (#23995)</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Betadine&#160;</td>
			<td style="width:171px;">Fisher Scientific</td>
			<td style="width:127px;">19-898-867&#160;</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">Q-tips</td>
			<td style="width:171px;">Multiple sellers&#160;</td>
			<td style="width:127px;">Catalog number not available&#160;</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Gauze Pads</td>
			<td style="width:171px;">Fisher Scientific</td>
			<td style="width:127px;">67622</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Surgical drape</td>
			<td style="width:171px;">Fisher Scientific</td>
			<td style="width:127px;">GM300&#160;</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">Silk Sutures&#160;</td>
			<td style="width:171px;">Look/Div Surgical Specialties</td>
			<td style="width:127px;">SP115</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">Nylon Sutures</td>
			<td style="width:171px;">Look/Div Surgical Specialties</td>
			<td style="width:127px;">SP185</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Durmont #5 forceps (2)&#160;</td>
			<td style="width:171px;">Fine Science Tools&#160;</td>
			<td style="width:127px;">11251-35</td>
			<td style="width:283px;">Angled 45&#176;</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Surgical Scissors</td>
			<td style="width:171px;">Fine Science Tools&#160;</td>
			<td style="width:127px;">14028-10</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">3mm Vannas</td>
			<td style="width:171px;">Kent Scientific Corporation</td>
			<td style="width:127px;">INS600177</td>
			<td style="width:283px;">Straight blade</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Hartman Hemostats&#160;</td>
			<td style="width:171px;">Fine Scientific Tools</td>
			<td style="width:127px;">13002-10</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="60">
			<td height="60" style="height:60px;width:249px;">Occluding filaments</td>
			<td style="width:171px;">Washington University</td>
			<td style="width:127px;">Specialty order</td>
			<td style="width:283px;">Filaments are silicone coated at Washington Univeristy and provided to UTSW facilities for a fee.&#160;</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Evans Blue</td>
			<td style="width:171px;">Sigma Aldritch</td>
			<td style="width:127px;">E2129-10G</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Filter Paper&#160;</td>
			<td style="width:171px;">Sigma Aldritch</td>
			<td style="width:127px;">WHA1001150</td>
			<td style="width:283px;">150 mm, circles, Grade 1&#160;</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Weigh Boats</td>
			<td style="width:171px;">Fisher Scientific</td>
			<td style="width:127px;">02-202-101</td>
			<td style="width:283px;">2.5&#34; diameter</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">0.9% Sodium Chloride Injection USP&#160;</td>
			<td style="width:171px;">Baxter Pharmaceutics&#160;</td>
			<td style="width:127px;">2B1321</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">0.3cc insulin syringe with 29 g needle</td>
			<td style="width:171px;">Becton Dickinson Labware</td>
			<td style="width:127px;">309301</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Flat bottom restrainer&#160;</td>
			<td style="width:171px;">Braintree Scientific&#160;</td>
			<td style="width:127px;">FB&#160;M</td>
			<td style="width:283px;">2.0&#34; diameter</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">TTC</td>
			<td style="width:171px;">Sigma</td>
			<td style="width:127px;">T8877</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">10X PBS, pH 7.4</td>
			<td style="width:171px;">Fisher Scientific</td>
			<td style="width:127px;">BP399-20</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="80">
			<td height="80" style="height:80px;width:249px;">Water Bath</td>
			<td style="width:171px;">Multiple sellers&#160;</td>
			<td style="width:127px;">Catalog number not available&#160;</td>
			<td style="width:283px;">Scintillation tubes with TTC may be manually held under running warm water as an alternative to the water bath.</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">Styrofoam board</td>
			<td style="width:171px;">Multiple sellers&#160;</td>
			<td style="width:127px;">Catalog number not available&#160;</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Large Syringe Kit</td>
			<td style="width:171px;">PumpSystems Inc</td>
			<td style="width:127px;">P-SYRKIT-LG</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Perfusion Pump</td>
			<td style="width:171px;">PumpSystems Inc</td>
			<td style="width:127px;">NE-300&#160;</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">60 cc syringe</td>
			<td style="width:171px;">Fisher Scientific</td>
			<td style="width:127px;">NC9203256</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">27g winged infusion set</td>
			<td style="width:171px;">Kawasumi Laboratories, Inc</td>
			<td style="width:127px;">D3K1-25G 1</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">20 ml scintillation vial</td>
			<td style="width:171px;">Fisher Scientific</td>
			<td style="width:127px;">50-367-126</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Stainless steel spatula</td>
			<td style="width:171px;">Fisher Scientific</td>
			<td style="width:127px;">14-373-25A</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">Alto acrylic 1.0 mm mouse brain, coronal</td>
			<td style="width:171px;">CellPoint Scientific&#160;</td>
			<td style="width:127px;">Catalog number not available&#160;</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">0.21 mm stainless steel blades, 25 pk</td>
			<td style="width:171px;">CellPoint Scientific&#160;</td>
			<td style="width:127px;">Catalog number not available&#160;</td>
			<td style="width:283px;">Reusable cryostat blades are an inexpensive alternative.</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">4% paraformaldehyde</td>
			<td style="width:171px;">Santa Cruz Biotechnology&#160;</td>
			<td style="width:127px;">SC-281692</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Superfrost microscope slides&#160;</td>
			<td style="width:171px;">Fisher Scientific</td>
			<td style="width:127px;">12-550-15</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">HP Scanjet G4050</td>
			<td style="width:171px;">Multiple sellers&#160;</td>
			<td style="width:127px;">Catalog number not available&#160;</td>
			<td style="width:283px;">Other commercial scanners are suitable for this step in the protocol.</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">ImageJ&#160;</td>
			<td style="width:171px;">National Institute of Health</td>
			<td style="width:127px;">Catalog number not available&#160;</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Analytical Balance</td>
			<td style="width:171px;">Mettler Toledo&#160;</td>
			<td style="width:127px;">XSE 205U</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Precision Compact Oven&#160;&#160;</td>
			<td style="width:171px;">Thermo Scientific&#160;</td>
			<td style="width:127px;">PR305225M</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">1.7 mL microcentrifuge tubes (Eppendorfs)</td>
			<td style="width:171px;">Denville Scientific&#160;</td>
			<td style="width:127px;">C2170</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">Formamide</td>
			<td style="width:171px;">Fisher Scientific</td>
			<td style="width:127px;">BP228-100</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:249px;">96-well plates</td>
			<td style="width:171px;">Fisher Scientific</td>
			<td style="width:127px;">07-200-9</td>
			<td style="width:283px;"></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:249px;">Epoch Microplate Spectrophotometer&#160;</td>
			<td style="width:171px;">BioTek&#160;</td>
			<td style="width:127px;">Catalog number not available&#160;</td>
			<td style="width:283px;"></td>
		</tr>
	</tbody>
</table>

quantification of neurovascular protection following repetitive hypoxic preconditioning and transient middle cerebral artery occlusion in mice

中风的实验动物模型是了解中风的病理和开发更有效的治疗策略非常宝贵的工具。 2周协议重复缺氧预处理（RHP）诱导长期保护，防止中枢神经系统（CNS）损伤的局灶性缺血性脑卒中的小鼠模型。 RHP由9随机暴露于缺氧该变化在两个持续时间（2或4小时）和强度（8％和11％的O 2）。 RHP减少梗死体积，血 - 脑屏障（BBB）的破坏，并为周后的最后暴露于缺氧的中风后的炎症反应，这表明了长期的感应的内源性的CNS保护表型。对于梗死体积和血脑屏障破坏的双重定量的方法是有效的评估小鼠RHP或其他神经保护剂推测神经血管的保护。成年雄性Swiss Webster小鼠被RHP或持续时间相当于曝光预处理到21％氧气<suB&gt; 2（ 即室内空气）。 60分钟短暂的大脑中动脉闭塞（tMCAo）诱导后2周的最后低氧暴露。无论是缺血再灌注经颅激光多普勒血流仪证实。二十二个小时再灌注后，伊文思蓝（EB）进行静脉内，通过尾静脉注射给药。 2小时后，将动物用异氟烷过量和脑切片处死沾满2,3,5-氯化三苯基四唑（TTC）。梗死体积再量化。接着，EB从组织中提取超过48小时tMCAo后确定血脑屏障破坏。总之，RHP是一个简单的协议，它可以被复制，以最少的成本，以诱导中风损伤小鼠长期内源性神经血管保护，与平移潜力其它CNS基和全身促炎疾病状态。

这项研究包括25男瑞士韦伯斯特小鼠为10周龄时随机开始进入RHP（N = 10）或21％O 2（N = 15）组。两周后的最终RHP曝光，外科手术进行，以盲基和天之间平衡。继tMCAo，1个鼠标术后恢复过程中死亡和1个鼠标被排除在研究，因为它不符合再灌注CBF标准。排除两种小鼠在21％O 2组。按照ARRIVE准则，28表2示出的外科参数。间接的梗死体积，半球肿胀（ 即 ，水肿），和伊文思?...

Watch this Scientific Journal Video about Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice at JoVE.com

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

This protocol describes repetitive hypoxic preconditioning, or brief exposures to systemic hypoxia that reduce infarct volumes and blood-brain barrier disruption following transient middle cerebral artery occlusion in mice. It also details dual quantification of infarct volume and blood-brain barrier disruption after stroke to assess the efficacy of neurovascular protection.

神经血管保护定量继在小鼠重复缺氧预处理和瞬态大脑中动脉闭塞

Experimental animal models of stroke are invaluable tools for understanding stroke pathology and developing more effective treatment strategies. A 2 week ...

quantification-neurovascular-protection-following-repetitive-hypoxic

Research

JoVE Journal

Medicine

13.6K 次观看.  University of Texas Southwestern Medical Center. This protocol describes repetitive hypoxic preconditioning, or brief exposures to systemic hypoxia that reduce infarct volumes and blood-brain barrier disruption following transient middle cerebral artery occlusion in mice. It also details dual quantification of infarct volume and blood-brain barrier disruption after stroke to assess the efficacy of neurovascular protection.

视频: Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Modeling Stroke in Mice - Middle Cerebral Artery Occlusion with the Filament Model

Stroke is among the most frequent causes of death and adult disability, especially in highly developed countries. However, treatment options to date are very limited. To meet the need for novel therapeutic approaches, experimental stroke research frequently employs rodent models of focal cerebral ischaemia. Most researchers use permanent or transient occlusion of the middle cerebral artery (MCA) in mice or rats.
Proximal occlusion of the middle cerebral artery (MCA) via the intraluminal suture technique (so called filament or suture model) is probably the most frequently used model in experimental stroke research. The intraluminal MCAO model offers the advantage of inducing reproducible transient or permanent ischaemia of the MCA territory in a relatively non-invasive manner. Intraluminal approaches interrupt the blood flow of the entire territory of this artery. Filament occlusion thus arrests flow proximal to the lenticulo-striate arteries, which supply the basal ganglia. Filament occlusion of the MCA results in reproducible lesions in the cortex and striatum and can be either permanent or transient. In contrast, models inducing distal (to the branching of the lenticulo-striate arteries) MCA occlusion typically spare the striatum and primarily involve the neocortex. In addition these models do require craniectomy. In the model demonstrated in this article, a silicon coated filament is introduced into the common carotid artery and advanced along the internal carotid artery into the Circle of Willis, where it blocks the origin of the middle cerebral artery. In patients, occlusions of the middle cerebral artery are among the most common causes of ischaemic stroke. Since varying ischemic intervals can be chosen freely in this model depending on the time point of reperfusion, ischaemic lesions with varying degrees of severity can be produced. Reperfusion by removal of the occluding filament at least partially models the restoration of blood flow after spontaneous or therapeutic (tPA) lysis of a thromboembolic clot in humans.
In this video we will present the basic technique as well as the major pitfalls and confounders which may limit the predictive value of this model.

Filamentous occlusion of the Middle cerebral artery is a common model for studying ischemic stroke in mice.

建模在小鼠体内的行程 - 中东与灯丝模型大脑中动脉闭塞

Stroke is among the most frequent causes of death and adult disability, especially in highly developed countries. However, treatment options to date are ...

科研

医学

Mouse Model of Middle Cerebral Artery Occlusion

Stroke is the most common fatal neurological disease in the United States 1. The majority of strokes (88%) result from blockage of blood vessels in the brain (ischemic stroke) 2. Since most ischemic strokes (~80%) occur in the territory of middle cerebral artery (MCA) 3, many animal stroke models that have been developed have focused on this artery. The intraluminal monofilament model of middle cerebral artery occlusion (MCAO) involves the insertion of a surgical filament into the external carotid artery and threading it forward into the internal carotid artery (ICA) until the tip occludes the origin of the MCA, resulting in a cessation of blood flow and subsequent brain infarction in the MCA territory 4. The technique can be used to model permanent or transient occlusion 5. If the suture is removed after a certain interval (30 min, 1 h, or 2 h), reperfusion is achieved (transient MCAO); if the filament is left in place (24 h) the procedure is suitable as a model of permanent MCAO. This technique does not require craniectomy, a neurosurgical procedure to remove a portion of skull, which may affect intracranial pressure and temperature 6. It has become the most frequently used method to mimic permanent and transient focal cerebral ischemia in rats and mice 7,8. To evaluate the extent of cerebral infarction, we stain brain slices with 2,3,5-triphenyltetrazolium chloride (TTC) to identify ischemic brain tissue 9. In this video, we demonstrate the MCAO method and the determination of infarct size by TTC staining.

We demonstrate in the video a method for producing a middle cerebral artery occlusion in adult mice using an intraluminal monofilament. We also show how to evaluate the extent of cerebral infarction by 2,3,5-triphenyltetrazolium chloride (TTC) staining.

大脑中动脉闭塞的小鼠模型

Stroke is the most common fatal neurological disease in the United States 1. The majority of strokes (88%) result from blockage of blood vessels in the ...

Intraluminal Middle Cerebral Artery Occlusion (MCAO) Model for Ischemic Stroke with Laser Doppler Flowmetry Guidance in Mice

Stroke is the third leading cause of death and the leading cause of disability in the world, with an estimated cost of near $70 billion 
in the United States in 20091,2. The intraluminal middle cerebral artery occlusion (MCAO) model was developed by Koizumi4 in 1986 to simulate this 
impactful human pathology in the rat. A modification of the MCAO method was later presented by Longa3. Both techniques have been widely used to identify 
molecular mechanisms of brain injury resulting from ischemic stroke and potential therapeutic modalities5. This relatively noninvasive method in rats has been 
extended to use in mice to take advantage of transgenic and knockout strains6,7. To model focal cerebral ischemia, an intraluminal suture is advanced via 
the internal carotid artery to occlude the base of the MCA. Retracting the suture after a specified period of time mimics spontaneous reperfusion, but the 
suture can also be permanently retained. This video will be demonstrating the two major approaches for performing intraluminal MCAO procedure in mice in a 
stepwise fashion, as well as providing insights for potential drawbacks and pitfalls. The ischemic brain tissue will subsequently be stained by 
2,3,5-triphenyltetrazolium chloride (TTC) to evaluate the extent of cerebral infarction8.

Intraluminal Middle Cerebral Artery Occlusion MCAO Model for Ischemic Stroke with Laser Doppler Flowmetry Guidance in Mice

The intraluminal middle cerebral artery occlusion (MCAO) model is the most frequent used model among experimental ischemic stroke models. Here we will demonstrate the entire model in detail with the guide of Laser Doppler flowmetry, and its representative results.

腔内中东大脑中动脉闭塞（MCAO）缺血性中风模型在小鼠体内的激光多普勒血流指导

Stroke is the third leading cause of death and the leading cause of disability in the world, with an estimated cost of near $70 billion 
in the United ...

Endothelin-1 Induced Middle Cerebral Artery Occlusion Model for Ischemic Stroke with Laser Doppler Flowmetry Guidance in Rat

Stroke is the number one cause of disability and third leading cause of death in the world, costing an estimated $70 billion in the United States in 20091, 2. Several models of cerebral ischemia have been developed to mimic the human condition of stroke. It has been suggested that up to 80% of all strokes result from ischemic damage in the middle cerebral artery (MCA) area3. In the early 1990s, endothelin-1 (ET-1) 4 was used to induce ischemia by applying it directly adjacent to the surface of the MCA after craniotomy. Later, this model was modified 5 by using a stereotaxic injection of ET-1 adjacent to the MCA to produce focal cerebral ischemia. The main advantages of this model include the ability to perform the procedure quickly, the ability to control artery constriction by altering the dose of ET-1 delivered, no need to manipulate the extracranial vessels supplying blood to the brain as well as gradual reperfusion rates that more closely mimics the reperfusion in humans5-7. On the other hand, the ET-1 model has disadvantages that include the need for a craniotomy, as well as higher variability in stroke volume8. This variability can be reduced with the use of laser Doppler flowmetry (LDF) to verify cerebral ischemia during ET-1 infusion. Factors that affect stroke variability include precision of infusion and the batch of the ET-1 used6. Another important consideration is that although reperfusion is a common occurrence in human stroke, the duration of occlusion for ET-1 induced MCAO may not closely mimic that of human stroke where many patients have partial reperfusion over a period of hours to days following occlusion9, 10. This protocol will describe in detail the ET-1 induced MCAO model for ischemic stroke in rats. It will also draw attention to special considerations and potential drawbacks throughout the procedure.

Several animal models of cerebral ischemia have been developed to simulate the human condition of stroke. This protocol describes the endothelin-1 (ET-1) induced middle cerebral artery occlusion (MCAO) model for ischemic stroke in rats. In addition, important considerations, advantages, and shortcomings of this model are discussed.

内皮素-1诱导大脑中动脉闭塞模型缺血性中风激光多普勒血流仪在大鼠指导

Stroke is the number one cause of disability and third leading cause of death in the world, costing an estimated $70 billion in the United States in ...

Utilizing a Cranial Window to Visualize the Middle Cerebral Artery During Endothelin-1 Induced Middle Cerebral Artery Occlusion

Creation of a cranial window is a method that allows direct visualization of structures on the cortical surface of the brain1-3. This technique can be performed in many locations overlying the rat cerebrum, but is most easily carried out by creating a craniectomy over the readily accessible frontal or parietal bones. Most frequently, we have used this technique in combination with the endothelin-1 middle cerebral artery occlusion model of ischemic stroke to quantify the changes in middle cerebral artery vessel diameter that occur with injection of endothelin-1 into the brain parenchyma adjacent to the proximal MCA4, 5. In order to visualize the proximal portion of the MCA during endothelin -1 induced MCAO, we use a technique to create a cranial window through the temporal bone on the lateral aspect of the rat skull (Figure 1). Cerebral arteries can be visualized either with the dura intact or with the dura incised and retracted. Most commonly, we leave the dura intact during visualization since endothelin-1 induced MCAO involves delivery of the vasoconstricting peptide into the brain parenchyma. This bypasses the need to incise the dura directly over the visualized vessels for drug delivery. This protocol will describe how to create a cranial window to visualize cerebral arteries in a step-wise fashion, as well as how to avoid many of the potential pitfalls pertaining to this method.

This article describes a method for visualizing rat cerebral arteries through a cranial window using temporal craniectomy in order to view proximal portions of the middle cerebral artery (Figure 1). This versatile method can be combined with various techniques of drug delivery to measure cerebral artery reactivity in vivo.

利用颅窗口，在可视化的大脑中动脉内皮素-1诱导大脑中动脉闭塞

Creation of a cranial window is a method that allows direct visualization of structures on the cortical surface of the brain1-3. This technique can be ...

Optimized System for Cerebral Perfusion Monitoring in the Rat Stroke Model of Intraluminal Middle Cerebral Artery Occlusion

The translational potential of pre-clinical stroke research depends on the accuracy of experimental modeling. Cerebral perfusion monitoring in animal models of acute ischemic stroke allows to confirm successful arterial occlusion and exclude subarachnoid hemorrhage. Cerebral perfusion monitoring can also be used to study intracranial collateral circulation, which is emerging as a powerful determinant of stroke outcome and a possible therapeutic target. Despite a recognized role of Laser Doppler perfusion monitoring as part of the current guidelines for experimental cerebral ischemia, a number of technical difficulties exist that limit its widespread use. One of the major issues is obtaining a secure and prolonged attachment of a deep-penetration Laser Doppler probe to the animal skull. In this video, we show our optimized system for cerebral perfusion monitoring during transient middle cerebral artery occlusion by intraluminal filament in the rat. We developed in-house a simple method to obtain a custom made holder for twin-fibre (deep-penetration) Laser Doppler probes, which allow multi-site monitoring if needed. A continuous and prolonged monitoring of cerebral perfusion could easily be obtained over the intact skull.

Cerebral perfusion monitoring has been demonstrated to improve accuracy in ischemic stroke models. Technical difficulties often limit the use of this essential tool for cerebrovascular research. In this video, an optimized system is shown to obtain a single or multi-site hemodynamic monitoring during intraluminal middle cerebral artery occlusion in rats.

优化系统的脑灌注监测在中风模型大鼠的大脑中动脉闭塞腔内

The translational potential of pre-clinical stroke research depends on the accuracy of experimental modeling. Cerebral perfusion monitoring in animal ...

Modeling Stroke in Mice: Permanent Coagulation of the Distal Middle Cerebral Artery

Stroke is the third most common cause of death and a main cause of acquired adult disability in developed countries. Only very limited therapeutical options are available for a small proportion of stroke patients in the acute phase. Current research is intensively searching for novel therapeutic strategies and is increasingly focusing on the sub-acute and chronic phase after stroke because more patients might be eligible for therapeutic interventions in a prolonged time window. These delayed mechanisms include important pathophysiological pathways such as post-stroke inflammation, angiogenesis, neuronal plasticity and regeneration. In order to analyze these mechanisms and to subsequently evaluate novel drug targets, experimental stroke models with clinical relevance, low mortality and high reproducibility are sought after. Moreover, mice are the smallest mammals in which a focal stroke lesion can be induced and for which a broad spectrum of transgenic models are available. Therefore, we describe here the mouse model of transcranial, permanent coagulation of the middle cerebral artery via electrocoagulation distal of the lenticulostriatal arteries, the so-called &#8220;coagulation model&#8221;. The resulting infarct in this model is located mainly in the cortex; the relative infarct volume in relation to brain size corresponds to the majority of human strokes. Moreover, the model fulfills the above-mentioned criteria of reproducibility and low mortality. In this video we demonstrate the surgical methods of stroke induction in the &#8220;coagulation model&#8221; and report histological and functional analysis tools.

Various murine models of middle cerebral artery occlusion (MCAO) are widely used in experimental brain research. Here, we demonstrate the model of transcranial permanent distal MCAO which produces consistent cortical infarction of a size corresponding to damage imposed by the majority of human ischemic strokes.

造型中风小鼠：在远端大脑中动脉永久性混凝

Stroke is the third most common cause of death and a main cause of acquired adult disability in developed countries. Only very limited therapeutical ...

Embolic Middle Cerebral Artery Occlusion (MCAO) for Ischemic Stroke with Homologous Blood Clots in Rats

Clinically, thrombolytic therapy with use of recombinant tissue plasminogen activator (tPA) remains the most effective treatment for acute ischemic stroke. However, the use of tPA is limited by its narrow therapeutic window and by increased risk of hemorrhagic transformation. There is an urgent need to develop suitable stroke models to study new thrombolytic agents and strategies for treatment of ischemic stroke. At present, two major types of ischemic stroke models have been developed in rats and mice: intraluminal suture MCAO and embolic MCAO. Although MCAO models via the intraluminal suture technique have been widely used in mechanism-driven stroke research, these suture models do not mimic the clinical situation and are not suitable for thrombolytic studies. Among these models, the embolic MCAO model closely mimics human ischemic stroke and is suitable for preclinical investigation of thrombolytic therapy. This embolic model was first developed in rats by Overgaard et al.1 in 1992 and further characterized by Zhang et al. in 19972. Although embolic MCAO has gained increasing attention, there are technical problems faced by many laboratories. To meet increasing needs for thrombolytic research, we present a highly reproducible model of embolic MCAO in the rat, which can develop a predictable infarct volume within the MCA territory. In brief, a modified PE-50 tube is gently advanced from the external carotid artery (ECA) into the lumen of the internal carotid artery (ICA) until the tip of the catheter reaches the origin of the MCA. Through the catheter, a single homologous blood clot is placed at the origin of the MCA. To identify the success of MCA occlusion, regional cerebral blood flow was monitored, neurological deficits and infarct volumes were measured. The techniques presented in this paper should help investigators to overcome technical problems for establishing this model for stroke research.

Embolic Middle Cerebral Artery Occlusion MCAO for Ischemic Stroke with Homologous Blood Clots in Rats

In this paper, we demonstrate a standard method for producing an embolic middle cerebral artery occlusion with homologous blood clots (fibrin-rich) in adult rat. This model closely mimics human ischemic stroke and is suitable for preclinical study of thrombolytic therapy for ischemic stroke.

栓塞性脑梗塞（缺血）的大鼠缺血性中风与血同源凝块

Clinically, thrombolytic therapy with use of recombinant tissue plasminogen activator (tPA) remains the most effective treatment for acute ischemic ...

Surgical Approach for Middle Cerebral Artery Occlusion and Reperfusion Induced Stroke in Mice

Stroke is a leading cause of death worldwide and continues to be one of the major causes of long-term adult disabilities. About 87% of strokes are ischemic in origin and occur in the territory of the middle cerebral artery (MCA). Currently the only Food and Drug Administration (FDA) approved drug for the treatment of this devastating disease is tissue plasminogen activator (tPA). However, tPA has a small therapeutic window for administration (3 - 6 hr), and is only effective in 4% of the patients who actually receive it. Current research focuses on understanding the pathophysiology of stroke in order to find potential therapeutic targets. Thus, reliable models are crucial, and the MCA occlusion (MCAo) model (also termed the intraluminal filament or suture model) is deemed to be the most clinically relevant surgical model of ischemic stroke, and is fairly non-invasive and easily reproducible. Typically the MCAo model is used with rodents, especially with mice due to all the genetic variations available for this species. Here we describe (and present in the video) how to successfully perform the MCAo model (with reperfusion) in mice to generate reliable and reproducible data.

In order to understand the pathophysiology of stroke, it is important to use reliable models. This paper will describe one of the most frequently used stroke models in mice, termed the middle cerebral artery occlusion (MCAo) model (also termed the intraluminal filament or suture model) with reperfusion.

对大脑中动脉闭塞再灌注损伤诱发中风小鼠的手术方法

Stroke is a leading cause of death worldwide and continues to be one of the major causes of long-term adult disabilities. About 87% of strokes are ...

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats

A number of animal models have been used to study hypoxic-ischemic injury, traumatic injury, global hypoxia, or permanent ischemia in both the immature and mature brain. Stroke occurs commonly in the perinatal period in humans, and transient ischemia-reperfusion is the most common form of stroke in neonates. The reperfusion phase is a critical component of injury progression, which occurs over a period of days to weeks, and of the endogenous response to injury. This postnatal day 10 (p10) rat model of transient middle cerebral artery occlusion (tMCAO) creates a unilateral, non-hemorrhagic focal ischemia-reperfusion injury that can be utilized to study the mechanisms of focal injury and repair in the full-term-equivalent brain. The injury pattern that is produced by tMCAO is consistent and highly reproducible and can be confirmed with MRI or histological analyses. The severity of injury can be manipulated through changes in occlusion time and other methods that will be discussed.

Neonatal stroke is a significant cause of early brain injury requiring a translational model with consistent focal injury patterns and high reproducibility in order to enable study. This study describes the detailed surgical procedure for creating a non-hemorrhagic, unilateral focal ischemia-reperfusion injury in full-term-equivalent rodents.

在P10大鼠新生儿中风的短暂大脑中动脉栓塞模型

A number of animal models have been used to study hypoxic-ischemic injury, traumatic injury, global hypoxia, or permanent ischemia in both the immature ...